Technical analysis of Calidi Biotherapeutics, Inc. (CLDI): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, dedicated to developing advanced immunotherapies for various cancers. The company's innovative approach centers on utilizing powerful, allogeneic (donor-derived) stem cells as specialized carriers for anti-tumor agents.
Price Performance
| 1 month | -7.87% |
| 3 months | -56.67% |
| Year-to-date | -93.75% |
| 1 year | -95.49% |
| 3 years | -99.98% |
52-Week Range
| 52-week High | $27.84 |
| 52-week Low | $1.16 |
| Avg Volume (90d) | 276K |
Technical Indicators
| SMA 50 | $1.58 |
| SMA 200 | $7.64 |
| Beta | 1.42 |
| 30-day Volatility (annualised) | 73.1% |
| Price vs SMA 50 | -25.9% |
| Price vs SMA 200 | -84.7% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $24.64 | |
| 2025-11 | $24.16 | -1.9% |
| 2025-12 | $18.72 | -22.5% |
| 2026-01 | $16.32 | -12.8% |
| 2026-02 | $12.72 | -22.1% |
| 2026-03 | $3.82 | -70.0% |
| 2026-04 | $3.79 | -0.8% |
| 2026-05 | $2.96 | -21.9% |
| 2026-06 | $2.72 | -8.1% |
| 2026-07 | $1.64 | -39.7% |
| 2026-08 | $1.34 | -18.3% |
| 2026-09 | $1.17 | -12.7% |
Price
| Price | $1.17 |
| Market Cap | $1M |
| Exchange | AMEX |
| Country | US |
Valuation Ratios
| Price / Book | 0.53 |
| EV / EBITDA | 0.09 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.62 |
| Current Ratio | 1.68 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -29.02 |